0001213900-24-108346.txt : 20241212 0001213900-24-108346.hdr.sgml : 20241212 20241212160511 ACCESSION NUMBER: 0001213900-24-108346 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241212 DATE AS OF CHANGE: 20241212 EFFECTIVENESS DATE: 20241212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeuroSense Therapeutics Ltd. CENTRAL INDEX KEY: 0001875091 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-531943 FILM NUMBER: 241544821 BUSINESS ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 BUSINESS PHONE: 972-9-9531142 MAIL ADDRESS: STREET 1: 11 HAMENOFIM ST. STREET 2: BUILDING B CITY: HERZLIYA STATE: L3 ZIP: 4672562 D 1 primary_doc.xml X0708 D LIVE 0001875091 NeuroSense Therapeutics Ltd. 11 HAMENOFIM STREET, BUILDING B HERZLIYA L3 ISRAEL 4672562 +972-9-7996183 ISRAEL None None Corporation true Alon Ben-Noon 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Director Chief Executive Officer Or Eisenberg 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Financial Officer Ferenc Tracik 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Medical Officer Hagit Binder 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Operating Officer Niva Russek-Blum 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Executive Officer Chief Technology Officer Christine Pelizzari 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Roy Golan 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Revital Mandil-Levin 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Mark Leuchtenberger 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Cary Claiborne 11 HaMenofim Street, Building B Herzliya L3 ISRAEL 4672562 Director Biotechnology Decline to Disclose 06b false 2024-12-05 true true true false 0 5000000 5000000 0 false 2 0 0 0 false NeuroSense Therapeutics Ltd. /s/ Alon Ben-Noon Alon Ben-Noon Chief Executive Officer 2024-12-12